Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Basavarajappa BS et al. |
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. |
2000 |
Biochim. Biophys. Acta |
pmid:11113634
|
Pryor SR |
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. |
2000 |
Med. Hypotheses |
pmid:11090297
|
Rhee MH et al. |
Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. |
2000 |
J. Neurochem. |
pmid:11080201
|
Sugiura T and Waku K |
2-Arachidonoylglycerol and the cannabinoid receptors. |
2000 |
Chem. Phys. Lipids |
pmid:11106784
|
Gallily R et al. |
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. |
2000 |
Eur. J. Pharmacol. |
pmid:11011050
|
Chen Y et al. |
Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. |
2000 |
Circ. Res. |
pmid:10948067
|
Suhara Y et al. |
Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. |
2000 |
Chem. Pharm. Bull. |
pmid:10923815
|
Járai Z et al. |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. |
2000 |
Hypertension |
pmid:10679517
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Sugiura T et al. |
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. |
2000 |
J. Biol. Chem. |
pmid:10617657
|
Hillard CJ |
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785538
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives in cancer and inflammation. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785541
|
Kunos G et al. |
Cardiovascular effects of endocannabinoids--the plot thickens. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785543
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
González S et al. |
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10733937
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|